Question
Is Fisetin legit?
In context of Fisetin·Insufficient evidence56/100
In our editorial model, Fisetin maps to a Insufficient evidence verdict at 56/100 overall (evidence 48/100, safety 72/100, hype gap 64/100). Senolytic marketing from rodent hype; Antioxidant. Typical label framing: Human senolytic trials ongoing; supplement megadosing not equivalent.
Full ingredient file
This page is a short answer. Mechanisms, dosing notes, sources, and the rest of the verdict live on the hub for Fisetin.
Open Fisetin verdictOther questions on Fisetin
A few more focused pages for the same ingredient (we keep lists short on purpose).